Adia Nutrition Inc. has officially filed for uplisting to the OTCQB Venture Market with OTC Markets Group. This move follows the completion of an independent audit, marking a significant milestone for the company. The uplisting process, facilitated by OTC Markets, aims to enhance transparency and investor reach, and improve market maker participation. Adia Nutrition continues to expand its network of clinics and advance its innovative stem cell therapies and premium nutritional products, aiming for greater market credibility and access to a wider investor base.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。